Cytopaenia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia (NCT02148133) | Novartis Pharmaceuticals | 2014-07-23 |
Track Cytopaenia automatically
Every clearance here is in the API, with alerts when new ones post.